Literature DB >> 26838299

Recovery from delirium and psychotic manifestations following treatment of anaemia with off-label rituximab in active cold haemagglutinin disease.

Michail Kaklamanos1, Sadie Regmi1, David Wrench2, Mark Kinirons1.   

Abstract

Anaemia is an independent, commonly under-recognised risk factor for delirium. Prompt management of anaemia and its underlying aetiology could result in recovery from delirium and associated psychotic manifestations. We report this unprecedented case of complete recovery from delirium and challenging behaviour, following treatment of autoimmune haemolytic anaemia with rituximab. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26838299      PMCID： PMC4746552          DOI： 10.1136/bcr-2015-213533

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  5 in total

Review 1.  Cold agglutinin disease.

Authors:  Paul L Swiecicki; Livia T Hegerova; Morie A Gertz
Journal:  Blood       Date:  2013-06-11       Impact factor: 22.113

2.  Is anaemia a risk factor for delirium in an acute geriatric population?

Authors:  Etienne Joosten; Joke Lemiengre; Tine Nelis; Geert Verbeke; Koen Milisen
Journal:  Gerontology       Date:  2006-08-17       Impact factor: 5.140

3.  Temporal relationship between neurotransmitter release and ion flux during spreading depression and anoxia.

Authors:  B Moghaddam; J O Schenk; W B Stewart; A J Hansen
Journal:  Can J Physiol Pharmacol       Date:  1987-05       Impact factor: 2.273

Review 4.  B12 deficiency and psychiatric disorders: case report and literature review.

Authors:  D K Zucker; R L Livingston; R Nakra; P J Clayton
Journal:  Biol Psychiatry       Date:  1981-02       Impact factor: 13.382

5.  Guidelines on the diagnosis and management of Waldenström macroglobulinaemia.

Authors:  Roger G Owen; Guy Pratt; Rebecca L Auer; Rita Flatley; Charalampia Kyriakou; Michael P Lunn; Francis Matthey; Helen McCarthy; Feargal P McNicholl; Saad M Rassam; Simon D Wagner; Matthew Streetly; Shirley D'Sa
Journal:  Br J Haematol       Date:  2014-02-15       Impact factor: 6.998
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.